Type 2 diabetes (T2D) patients with co-morbid fatty liver disease who undergo gastric bypass surgery are more likely to experience long-term diabetes remission than are T2D patients without fatty liver, according to a large retrospective analysis by Cleveland Clinic researchers.
“EDGE” Now Available for Gastric Bypass Patients with Pancreatic and Bile Duct Issues
Patients with gastric bypass surgery have an altered anatomy that can make it difficult for physicians to treat problems in the pancreas or bile duct.
When Bariatric Surgery Comes Up Short: Probing the Behavioral-Biological Reasons
Cleveland Clinic is co-directing a newly launched NIH clinical trial that aims to better understand — and potentially target — the mind and body factors behind suboptimal bariatric surgery outcomes.
Study Looks at Insulin Requirements After Bariatric Surgery
At AACE Cleveland Clinic researchers presented results of a study comparing pre- and post-operative insulin regimens and dosages in patients with T2D who had undergone gastric bypass.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Long-Term Metabolic Effects of Gastric Bypass in Obese Patients with Type 2 Diabetes
Cleveland Clinic study finds gastric bypass surgery is a viable option for obese patients and should be considered early in the course of type 2 diabetes treatment.